Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber. The content of this letter is provided below. https://mma.prnewswire.com/media/1768046/Soligenix_Logo.jpg Dear […]

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg The

Conference Call Scheduled for Wednesday, July 30, 2025 at 11:00 a.m. Eastern Time W. P. Carey Inc. (W. P. Carey, NYSE: WPC), a leading net lease REIT, announced today that it will release its financial results for the second quarter ended June 30, 2025 after the market closes on Tuesday, July 29, 2025. The company

Valor Exterior Partners, a portfolio company of Osceola Capital, is pleased to announce the successful acquisition of Kirkin Exteriors, expanding Valor's presence into Delaware. Founded in 2011 and headquartered in New Castle, Delaware, Kirkin is a provider of roofing, siding, solar and other exterior home services to residential homeowners in Delaware, Maryland, Pennsylvania and New

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=155911&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Vestis Corporation (NYSE:VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vestis-corporation-lawsuit-submission-form?prid=155910&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that it has entered into a share and warrant purchase agreement (the “Purchase Agreement”) with an institutional investor for the issuance and

COLORADO SPRINGS, Colo., July 08, 2025 (GLOBE NEWSWIRE) — Sanborn Geophysics ULC, a subsidiary of The Sanborn Map Company, today announced a major step in its evolution from general geophysical solutions to a product-driven model capable of meeting growing global demand. Since its acquisition, the company has doubled its production output, overhauled its software platform,

E-Cite to Modernize another Iconic American Sportscar- the Kaiser-Darrin BOTHELL, WASHINGTON / ACCESS Newswire / July 8, 2025 / Innovative EV Technologies, Inc., formerly VaporBrands International, Inc. dba E-Cite Motors Group, (OTCID:VAPR) an innovative low-volume automobile manufacturer, proudly announces it has secured the design and production rights to the iconic Kaiser-Darrin, one of America’s most

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=155909&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at